Automated Immunoassay Analysers Market is expected to grow at a CAGR of 16% during the forecast period and market is expected to reach US$ 29.53 Bn. by 2029. The growth is coupled with a rising shift in trend towards lab automated coupled with the increasing prevalence of infectious diseases. These products are gaining popularity due to incremental innovation to the existing products and extended clinical applications. Current trends of automation and integration has led to the introduction of innovative products in the market, thus driving the Global Automated Immunoassay Analysers Market. Various pharmaceutical and biotechnology companies are increasingly using them for drug discovery purposes.To know about the Research Methodology :- Request Free Sample Report Industry players are competing on the basis immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories. North America Automated Immunoassay Analysers market dominated the overall sector and is expected to maintain its dominance during the study period. The market is driven by the strategic presence of key manufacturers. High adoption of technology in the U.S. and rising demand for clinically efficient immunoassay analyzers are the major factors drive the market through the forecast period. U.S. automated immunoassay analyzers market contributed more than 85% to the regional revenue share in 2021. Favorable government policies and rapid adoption of automated technology in diagnostic laboratories should contribute to business growth. Asia-Pacific is expected to have higher growth rate driven by China. China Global Automated Immunoassay Analysers Market improving healthcare infrastructure and huge patient pool available for diagnostic testing. Moreover, the entry of leading manufacturers in this region should provide promising regional growth opportunities in the coming years. Hospitals accounted for the largest revenue share owing to the consolidation trend among hospitals leading to high test volumes, and favorable health reforms to provide better hospital care. Moreover, the increasing number of corporate hospital chains should also boost Global Automated Immunoassay Analysers Market demand over the forecast years. Other factors including the rising number of hospitals. The use of automated systems helps hospitals to use their skilled resources for more important activities such as analysis and test results review. The objective of the report is to present comprehensive Global Automated Immunoassay Analysers Market Device Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Automated Immunoassay Analysers Market Device Market North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Automated Immunoassay Analysers Market Device Market North America for Asia Pacific size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Automated Immunoassay Analysers Market Device Market North America for Asia Pacific make the report investor’s guide.
Automated Immunoassay Analysers Market Scope: Inquire before buying
Global Automated Immunoassay Analysers Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 9 Bn. Forecast Period 2022 to 2029 CAGR: 16% Market Size in 2029: US $ 29.53 Bn. Segments Covered: By Technology • Chemiluminescence Immunoassay (CLIA) • Enzyme Linked Fluorescent Immunoassay (ELFA) • Enzyme-linked Immunosorbent Assay (ELISA) • Radioimmunoassay (RIA) • Others By Sales Model • Reagent Rental / Lease • Outright Sale By Applications • Infectious diseases • Endocrinology • Drug Monitoring • Cardiology • Oncology • Allergy Testing • Others By End-User • Hospitals • Diagnostic Laboratories • Blood Banks • Others Automated Immunoassay Analysers Market, by Region
North America Europe Asia Pacific Latin America Middle East and AfricaWhat information is covered in the Report?
• Actual market numbers from 2021-2029, estimates and forecasts from 2021 to 2029 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2021Automated Immunoassay Analysers Market Key Players are:
• Siemens Healthineers • Abbott Laboratories • bioMérieux SA • Bio-Rad Laboratories, Inc • Pall Corporation • Beckman Coulter, Inc. • Sigma-Aldrich Corporation • Sartorius AG • Ortho Clinical Diagnostics • Radiometer APS • Sartorius • Danaher • Randox Laboratories • F. Hoffmann-La Roche Ltd. • DiaSorin S.p.A. • Agilent Technologies • SNIBE Diagnostics • Pfizer Inc. • Hospitech • CSL Behring Frequently Asked Questions: 1. Which region has the largest share in Global Automated Immunoassay Analysers Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Automated Immunoassay Analysers Market? Ans: The Global Automated Immunoassay Analysers Market is growing at a CAGR of 16% during forecasting period 2022-2029. 3. What is scope of the Global Automated Immunoassay Analysers market report? Ans: Global Automated Immunoassay Analysers Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Automated Immunoassay Analysers market? Ans: The important key players in the Global Automated Immunoassay Analysers Market are – Siemens Healthineers, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc, Pall Corporation, Beckman Coulter, Inc., Sigma-Aldrich Corporation, Sartorius AG, Ortho Clinical Diagnostics, Radiometer APS, Sartorius, Danaher, Randox Laboratories, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Agilent Technologies, SNIBE Diagnostics, Pfizer Inc., Hospitech, and CSL Behring 5. What is the study period of this market? Ans: The Global Automated Immunoassay Analysers Market is studied from 2021 to 2029.
Global Automated Immunoassay Analysers Market
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Automated Immunoassay Analyzers Market overview 2.1.1. By Technology 2.1.2. By Sales Model 2.1.3. By End-Use 2.1.4. By Applications Chapter 3 Global Automated Immunoassay Analyzers Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing Incidence of Disease Epidemics 3.2.1.2. Modernization of healthcare facilities in emerging economies 3.2.2. Market Restrains 3.2.2.1. Declining Reimbursement Policies 3.3. Market share analysis 3.3.1. By Technology 3.3.2. By Sales Model 3.3.3. By End-Use 3.3.4. By Applications 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Automated Immunoassay Analyzers Market, By Technology 4.1. Key segment trends 4.2. Chemiluminescence Immunoassay (CLIA) 4.2.1. Market size, by region, 2022-2029 4.3. Enzyme Linked Fluorescent Immunoassay (ELFA) 4.3.1. Market size, by region, 2022-2029 4.4. Enzyme linked Immunosorbent Assay (ELISA) 4.4.1. Market size, by region, 2022-2029 4.5. Radioimmunoassay (RIA) 4.5.1. Market size, by region, 2022-2029 4.6. Others 4.6.1. Market size, by region, 2022-2029 Chapter 5 Automated Immunoassay Analyzers Market, By Applications 5.1. Key segment trends 5.2. Infectious diseases 5.2.1. Market size, by region, 2022-2029 5.3. Endocrinology 5.3.1. Market size, by region, 2022-2029 5.4. Drug Monitoring 5.4.1. Market size, by region, 2022-2029 5.5. Cardiology 5.5.1. Market size, by region, 2022-2029 5.6. Oncology 5.6.1. Market size, by region, 2022-2029 5.7. Allergy Testing 5.7.1. Market size, by region, 2022-2029 5.8. Others 5.8.1. Market size, by region, 2022-2029 Chapter 6 Automated Immunoassay Analyzers Market, By End-Use 6.1. Key segment trends 6.2. Hospitals 6.2.1. Market size, by region, 2022-2029 6.3. Diagnostic Laboratories 6.3.1. Market size, by region, 2022-2029 6.4. Blood Banks 6.4.1. Market size, by region, 2022-2029 6.5. Others 6.5.1. Market size, by region, 2022-2029 Chapter 7 Automated Immunoassay Analyzers Market, By Sales Model 7.1. Key segment trends 7.2. Reagent Rental / Lease 7.2.1. Market size, by region, 2022-2029 7.3. Outright Sale 7.3.1. Market size, by region, 2022-2029 Chapter 8 Automated Immunoassay Analyzers Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2022-2029 8.2.2. Market size, by end-use, 2022-2029 8.2.3. Market size, by technology, 2022-2029 8.2.4. Market size, by applications, 2022-2029 8.2.5. Market size, by sales model, 2022-2029 8.2.6. U.S. 8.2.6.1. Market size, by end-use, 2022-2029 8.2.6.2. Market size, by technology, 2022-2029 8.2.6.3. Market size, by applications, 2022-2029 8.2.6.4. Market size, by sales model, 2022-2029 8.2.7. Canada 8.2.7.1. Market size, by end-use, 2022-2029 8.2.7.2. Market size, by technology, 2022-2029 8.2.7.3. Market size, by applications, 2022-2029 8.2.7.4. Market size, by sales model, 2022-2029 8.3. Europe 8.3.1. Market size, by country, 2022-2029 8.3.2. Market size, by end-use, 2022-2029 8.3.3. Market size, by technology, 2022-2029 8.3.4. Market size, by applications, 2022-2029 8.3.5. Market size, by sales model, 2022-2029 8.3.6. Germany 8.3.6.1. Market size, by end-use, 2022-2029 8.3.6.2. Market size, by technology, 2022-2029 8.3.6.3. Market size, by applications, 2022-2029 8.3.6.4. Market size, by sales model, 2022-2029 8.3.7. UK 8.3.7.1. Market size, by end-use, 2022-2029 8.3.7.2. Market size, by technology, 2022-2029 8.3.7.3. Market size, by applications, 2022-2029 8.3.7.4. Market size, by sales model, 2022-2029 8.3.8. France 8.3.8.1. Market size, by end-use, 2022-2029 8.3.8.2. Market size, by technology, 2022-2029 8.3.8.3. Market size, by applications, 2022-2029 8.3.8.4. Market size, by sales model, 2022-2029 8.3.9. Spain 8.3.9.1. Market size, by end-use, 2022-2029 8.3.9.2. Market size, by technology, 2022-2029 8.3.9.3. Market size, by applications, 2022-2029 8.3.9.4. Market size, by sales model, 2022-2029 8.3.10. Italy 8.3.10.1. Market size, by end-use, 2022-2029 8.3.10.2. Market size, by technology, 2022-2029 8.3.10.3. Market size, by applications, 2022-2029 8.3.10.4. Market size, by sales model, 2022-2029 8.4. Asia Pacific 8.4.1. Market size, by country, 2022-2029 8.4.2. Market size, by end-use, 2022-2029 8.4.3. Market size, by technology, 2022-2029 8.4.4. Market size, by applications, 2022-2029 8.4.5. Market size, by sales model, 2022-2029 8.4.6. India 8.4.6.1. Market size, by end-use, 2022-2029 8.4.6.2. Market size, by technology, 2022-2029 8.4.6.3. Market size, by applications, 2022-2029 8.4.6.4. Market size, by sales model, 2022-2029 8.4.7. China 8.4.7.1. Market size, by end-use, 2022-2029 8.4.7.2. Market size, by technology, 2022-2029 8.4.7.3. Market size, by applications, 2022-2029 8.4.7.4. Market size, by sales model, 2022-2029 8.4.8. Japan 8.4.8.1. Market size, by end-use, 2022-2029 8.4.8.2. Market size, by technology, 2022-2029 8.4.8.3. Market size, by applications, 2022-2029 8.4.8.4. Market size, by sales model, 2022-2029 8.4.9. Australia 8.4.9.1. Market size, by end-use, 2022-2029 8.4.9.2. Market size, by technology, 2022-2029 8.4.9.3. Market size, by applications, 2022-2029 8.4.9.4. Market size, by sales model, 2022-2029 8.5. Latin America 8.5.1. Market size, by country, 2022-2029 8.5.2. Market size, by end-use, 2022-2029 8.5.3. Market size, by technology, 2022-2029 8.5.4. Market size, by applications, 2022-2029 8.5.5. Market size, by sales model, 2022-2029 8.5.6. Argentina 8.5.6.1. Market size, by end-use, 2022-2029 8.5.6.2. Market size, by technology, 2022-2029 8.5.6.3. Market size, by applications, 2022-2029 8.5.6.4. Market size, by sales model, 2022-2029 8.5.7. Brazil 8.5.7.1. Market size, by end-use, 2022-2029 8.5.7.2. Market size, by technology, 2022-2029 8.5.7.3. Market size, by applications, 2022-2029 8.5.7.4. Market size, by sales model, 2022-2029 8.5.8. Mexico 8.5.8.1. Market size, by end-use, 2022-2029 8.5.8.2. Market size, by technology, 2022-2029 8.5.8.3. Market size, by applications, 2022-2029 8.5.8.4. Market size, by sales model, 2022-2029 8.6. Middle East and Africa 8.6.1. Market size, by country, 2022-2029 8.6.2. Market size, by end-use, 2022-2029 8.6.3. Market size, by technology, 2022-2029 8.6.4. Market size, by applications, 2022-2029 8.6.5. Market size, by sales model, 2022-2029 8.6.6. South Africa 8.6.6.1. Market size, by end-use, 2022-2029 8.6.6.2. Market size, by technology, 2022-2029 8.6.6.3. Market size, by applications, 2022-2029 8.6.6.4. Market size, by sales model, 2022-2029 8.6.7. Saudi Arabia 8.6.7.1. Market size, by end-use, 2022-2029 8.6.7.2. Market size, by technology, 2022-2029 8.6.7.3. Market size, by applications, 2022-2029 8.6.7.4. Market size, by sales model, 2022-2029 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. Siemens Healthineers 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. Abbott Laboratories 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. bioMérieux SA 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. Bio-Rad Laboratories, Inc. 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Pall Corporation 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. Beckman Coulter, Inc. 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Sigma-Aldrich Corporation 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.4.8. Sartorius AG 9.4.8.1. Company overview 9.4.8.2. Key financials 9.4.8.3. Product landscape 9.4.8.4. Strategic initiatives 9.4.8.5. SWOT analysis 9.4.9. Ortho Clinical Diagnostics 9.4.9.1. Company overview 9.4.9.2. Key financials 9.4.9.3. Product landscape 9.4.9.4. Strategic initiatives 9.4.9.5. SWOT analysis 9.4.10. Radiometer APS 9.4.10.1. Company overview 9.4.10.2. Key financials 9.4.10.3. Product landscape 9.4.10.4. Strategic initiatives 9.4.10.5. SWOT analysis 9.4.11. Sartorius 9.4.11.1. Company overview 9.4.11.2. Key financials 9.4.11.3. Product landscape 9.4.11.4. Strategic initiatives 9.4.11.5. SWOT analysis 9.4.12. Danaher 9.4.12.1. Company overview 9.4.12.2. Key financials 9.4.12.3. Product landscape 9.4.12.4. Strategic initiatives 9.4.12.5. SWOT analysis 9.4.13. Randox Laboratories 9.4.13.1. Company overview 9.4.13.2. Key financials 9.4.13.3. Product landscape 9.4.13.4. Strategic initiatives 9.4.13.5. SWOT analysis 9.4.14. F. Hoffmann-La Roche Ltd. 9.4.14.1. Company overview 9.4.14.2. Key financials 9.4.14.3. Product landscape 9.4.14.4. Strategic initiatives 9.4.14.5. SWOT analysis 9.4.15. DiaSorin S.p.A. 9.4.15.1. Company overview 9.4.15.2. Key financials 9.4.15.3. Product landscape 9.4.15.4. Strategic initiatives 9.4.15.5. SWOT analysis 9.4.16. Agilent Technologies 9.4.16.1. Company overview 9.4.16.2. Key financials 9.4.16.3. Product landscape 9.4.16.4. Strategic initiatives 9.4.16.5. SWOT analysis 9.4.17. CSL Behring 9.4.17.1. Company overview 9.4.17.2. Key financials 9.4.17.3. Product landscape 9.4.17.4. Strategic initiatives 9.4.17.5. SWOT analysis 9.4.18. SNIBE Diagnostics 9.4.18.1. Company overview 9.4.18.2. Key financials 9.4.18.3. Product landscape 9.4.18.4. Strategic initiatives 9.4.18.5. SWOT analysis 9.4.19. Pfizer Inc. 9.4.19.1. Company overview 9.4.19.2. Key financials 9.4.19.3. Product landscape 9.4.19.4. Strategic initiatives 9.4.19.5. SWOT analysis 9.4.20. Hospitech 9.4.20.1. Company overview 9.4.20.2. Key financials 9.4.20.3. Product landscape 9.4.20.4. Strategic initiatives 9.4.20.5. SWOT analysis